Spinal cord stimulation can reduce pain and restore nerve function among patients with diabetic peripheral neuropathy.

A cell therapy for regenerating broken spinal cord using lab-grown neurons enters human trials for the first time.

By analyzing DNA and proteins in the blood of people with and without acute spinal cord injuries (SCIs), researchers at the Johns Hopkins University School of Medicine have developed a novel blood ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...

Recent technological advances have enabled the development of a wide range of increasingly sophisticated wearable and ...

Paradromics, a brain-computer-interface startup, inserted its brain implant in a person—briefly—in an early test of its ...

Neuroscientists can now make precise genetic tweaks to the neurons that are most affected by brain diseases such as Parkinson ...

Paradromics implanted—then removed—the device in an epileptic patient. The goal is to help people with conditions like ALS.

Paradromics Inc. completed its first human procedure with the Connexus BCI, marking a milestone in brain-computer interface technology for epilepsy treatment.

Neuralink competitor Paradromics plans to conduct the first clinical trial of its Connexus brain implant later this year.

Spinal cord injury (SCI) is a devastating, debilitating, and life-altering condition that currently lacks a definitive cure or highly effective treatment ...

Surgical supply and equipment company MellingMedical has entered an agreement with Joimax, a developer of full-endoscopic and minimally invasive spinal surgery products. MellingMedical is an Small ...